Grey matter atrophy in early versus late dementia in Parkinson's disease

Parkinsonism and Related Disorders

Volumn 14, Issue 8, 2008, Pages 620-625

  Beyer, M K ^a   Aarsland, D ^a,b  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Atrophy; Dementia; MRI; Parkinson's disease

Indexed keywords

AGED; ARTICLE; BRAIN ATROPHY; BRAIN CORTEX ATROPHY; CLINICAL ARTICLE; DEMENTIA; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GRAY MATTER; HUMAN; INSULA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ATROPHY; CEREBRAL CORTEX; DEMENTIA; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PARKINSON DISEASE; STATISTICS, NONPARAMETRIC;

EID: 55749106380     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2008.01.021     Document Type: Article

References (44)

1. Aarsland D., Andersen K., Larsen J.P., Lolk A., and Kragh-Sorensen P. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 60 3 (2003 Apr) 387-392
2. Emre M. Dementia associated with Parkinson's disease. Lancet Neurol 2 4 (2003 May) 229-237
3. Aarsland D., Litvan I., Salmon D., Galasko D., Wentzel-Larsen T., and Larsen J.P. Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease. J Neurol Neurosurg Psychiatr 74 9 (2003 Oct) 1215-1220
4. Gelb D.J., Oliver E., and Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 56 1 (1999 Jan) 33-39
5. Ouchi Y., Yoshikawa E., Okada H., Futatsubashi M., Sekine Y., Iyo M., et al. Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: compartment analysis for beta-CFT binding with positron emission tomography. Ann Neurol 45 5 (1999 May) 601-610
6. Tiraboschi P., Hansen L.A., Alford M., Sabbagh M.N., Schoos B., Masliah E., et al. Cholinergic dysfunction in diseases with Lewy bodies. Neurology 54 2 (2000 Jan 25) 407-411
7. Bohnen N.I., Kaufer D.I., Ivanco L.S., Lopresti B., Koeppe R.A., Davis J.G., et al. Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. Arch Neurol 60 12 (2003 Dec) 1745-1748
8. Tsuboi Y., and Dickson D.W. Dementia with Lewy bodies and Parkinson's disease with dementia: are they different?. Parkinsonism Relat Disord 11 Suppl. 1 (2005 Jun) S47-S51
9. Aarsland D., Perry R., Brown A., Larsen J.P., and Ballard C. Neuropathology of dementia in Parkinson's disease: a prospective, community-based study. Ann Neurol 58 5 (2005 Nov) 773-776
10. Harding A.J., and Halliday G.M. Cortical Lewy body pathology in the diagnosis of dementia. Acta Neuropathol (Berl) 102 4 (2001 Oct) 355-363
11. Harding A.J., Broe G.A., and Halliday G.M. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain 125 Pt 2 (2002 Feb) 391-403
12. Foltynie T., Brayne C., and Barker R.A. The heterogeneity of idiopathic Parkinson's disease. J Neurol 249 2 (2002 Feb) 138-145
13. Aarsland D., Kvaloy J.T., Andersen K., Larsen J.P., Tang M.X., Lolk A., et al. The effect of age of onset of PD on risk of dementia. J Neurol 254 1 (2007 Feb 16) 38-45
14. Janvin C.C., Larsen J.P., Aarsland D., and Hugdahl K. Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia. Mov Disord 21 9 (2006 Sep) 1343-1349
15. Aarsland D., Andersen K., Larsen J.P., Perry R., Wentzel-Larsen T., Lolk A., et al. The rate of cognitive decline in Parkinson disease. Arch Neurol 61 12 (2004 Dec) 1906-1911
16. Galvin J.E., Pollack J., and Morris J.C. Clinical phenotype of Parkinson disease dementia. Neurology 67 9 (2006 Nov 14) 1605-1611
17. Alves G., Larsen J.P., Emre M., Wentzel-Larsen T., and Aarsland D. Changes in motor subtype and risk for incident dementia in Parkinson's disease. Mov Disord 21 8 (2006 Aug) 1123-1130
18. Ballard C., Ziabreva I., Perry R., Larsen J.P., O'Brien J., McKeith I., et al. Differences in neuropathologic characteristics across the Lewy body dementia spectrum. Neurology 67 11 (2006 Dec 12) 1931-1934
19. Burton E.J., McKeith I.G., Burn D.J., Williams E.D., and O' Brien J.T. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain 127 Pt 4 (2004 Apr) 791-800
20. Beyer M.K., Janvin C.C., Larsen J.P., and Aarsland D. A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry. J Neurol Neurosurg Psychiatr 78 3 (2007 Mar) 254-259
21. Beyer M.K., Larsen J.P., and Aarsland D. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies. Neurology 69 8 (2007 Aug 21) 747-754
22. Larsen J.P., Dupont E., and Tandberg E. Clinical diagnosis of Parkinson's disease. Proposal of diagnostic subgroups classified at different levels of confidence. Acta Neurol Scand 89 4 (1994 May) 242-251
23. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, DSM IV. 4th ed. (1996)
24. McKeith I.G., Dickson D.W., Lowe J., Emre M., O'Brien J.T., Feldman H., et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65 12 (2005 Dec 27) 1863-1872
25. Fahn S., Elton R., and Committee MotUD. In: Fahn S., Marsden, Calne D., and Lieberman A. (Eds). Unified Parkinson's disease rating scale (1987), Macmillan Health Care Information, Florham Park, NJ
26. Hoehn M.M., and Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology 17 5 (1967 Jun) 427-442
27. Folstein M.F., Folstein S.E., and Mc Hugh P.R. "Mini - mental State". A practical method for grading the mental state of patients for the clinician. J Psychiatr Res 12 (1975) 189-198
28. Mattis S. In: Bellak L., and TB K. (Eds). Dementia rating scale (1976), Grune and Stratton, New York
29. Roth M., Tym E., Mountjoy C.Q., Huppert F.A., Hendrie H., Verma S., et al. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 149 (1986) 698-709
30. Ashburner J., and Friston K.J. Voxel-based morphometry-the methods. Neuroimage 11 6 Pt 1 (2000 June) 805-821
31. Good C.D., Johnsrude I.S., Ashburner J., Henson R.N.A., Friston K.J., and Frackowiak R.S.J. A voxel-based Morphometric study of ageing in 465 normal adult human brains. Neuroimage 14 (2001 May 11) 21-36
32. Friston K.J., Holmes A., Poline J.B., Price C.J., and Frith C.D. Detecting activations in PET and fMRI: levels of inference and power. Neuroimage 4 3 Pt 1 (1996) 223-235
33. Lancaster J.L., Woldorff M.G., Parsons L.M., Liotti M., Freitas C.S., Rainey L., et al. Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp 10 3 (2000 Aug) 120-131
34. Talairach J., and Tournoux P. Co-planar stereotaxic atlas of the human brain. 3-Dimensional proportional system: an approach to cerebral imaging (1988), Thieme Medical Publishers, Inc, Stuttgart, New York
35. Summerfield C., Junque C., Tolosa E., Salgado-Pineda P., Gomez-Anson B., Marti M.J., et al. Structural brain changes in Parkinson disease with dementia: a voxel-based morphometry study. Arch Neurol 62 2 (2005 Feb) 281-285
36. Almeida O.P., Burton E.J., McKeith I., Gholkar A., Burn D., and O'Brien J.T. MRI study of caudate nucleus volume in Parkinson's disease with and without dementia with Lewy bodies and Alzheimer's disease. Dement Geriatr Cogn Disord 16 2 (2003) 57-63
37. Ramirez-Ruiz B., Marti M.J., Tolosa E., Bartres-Faz D., Summerfield C., Salgado-Pineda P., et al. Longitudinal evaluation of cerebral morphological changes in Parkinson's disease with and without dementia. J Neurol 252 11 (2005 Nov) 1345-1352
38. Dagher A., Owen A.M., Boecker H., and Brooks D.J. The role of the striatum and hippocampus in planning: a PET activation study in Parkinson's disease. Brain 124 Pt 5 (2001 May) 1020-1032
39. Monchi O., Petrides M., Mejia-Constain B., and Strafella A.P. Cortical activity in Parkinson's disease during executive processing depends on striatal involvement. Brain 130 Pt 1 (2007 Jan) 233-244
40. 18F]fluoro-l-dopa PET study. Brain 125 Pt 6 (2002 Jun) 1358-1365
41. Marras C., Rochon P., and Lang A.E. Predicting motor decline and disability in Parkinson disease: a systematic review. Arch Neurol 59 11 (2002 Nov) 1724-1728
42. Alves G., Wentzel-Larsen T., Aarsland D., and Larsen J.P. Progression of motor impairment and disability in Parkinson disease: a population-based study. Neurology 65 9 (2005 Nov 8) 1436-1441
43. Burton E.J., McKeith I.G., Burn D.J., and O'Brien J.T. Brain atrophy rates in Parkinson's disease with and without dementia using serial magnetic resonance imaging. Mov Disord 20 12 (2005 Dec) 1571-1576
44. Braak H., Ghebremedhin E., Rub U., Bratzke H., and Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 318 1 (2004 Oct) 121-134